Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Polymers|July 29, 2023
Nanomaterials Reinforced Polymer Filament for Fused Deposition Modeling: A State-of-the-Art ReviewXinchun Luo, Hailong Cheng, Xin Wu
Clinical Pharmacology in Drug Development|June 2, 2016
A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy VolunteersSoujanya Sunkaraneni, Jahnavi Kharidia, Ralph Schutz, et al.
Polymers|April 10, 2019
Ethylene Polymerization and Copolymerization with Polar Monomers Using Nickel Complexes Bearing Anilinobenzoic Acid Methyl Ester LigandHailong Cheng, Yue Su, Yanming Hu, et al.
Epilepsia Open|March 29, 2018
Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trialsMar Carreño, Selim Benbadis, Francisco Rocha, et al.
Nanoscale|April 27, 2023
Recent progresses on ion beam irradiation induced structure and performance modulation of two-dimensional materialsXin Wu, Xinchun Luo, Hailong Cheng, et al.
Epilepsia|February 18, 2015
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North AmericaMichael R Sperling, Jay Harvey, Todd Grinnell, et al.
Polymers|April 12, 2019
Living Polymerization of Propylene with ansa-Dimethylsilylene(fluorenyl)(cumylamido) Titanium ComplexesHuajin Wang, Xinwei Wang, Yanjie Sun, et al.
Journal of Colloid and Interface Science|May 19, 2026
Interfacial tandem catalysis in Co/WC heterojunctions for efficient nitrate-to-ammonia electrosynthesisXiangfa Zhu, Linjiao Zhou, Hailong Cheng, et al.
Epilepsy & Behavior : E&B|June 18, 2016
Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trialNaama Levy-Cooperman, Kerri A Schoedel, Bijan Chakraborty, et al.
BMC Neurology|April 17, 2015
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III studyMercedes P Jacobson, Ladislav Pazdera, Perminder Bhatia, et al.
Pageof 3